Results of the Staged Surgical Approach for Management of Infected Un-united Femoral Shaft Fractures in Adults

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04681846
Collaborator
(none)
40
19

Study Details

Study Description

Brief Summary

Assessment of the efficacy of the multistage technique in the eradication of infection and achieving the union of traumatic infected femoral un-united shaft fractures in adult patients for one year follow up.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Staged approach using antibiotic-cement impregnated PMMA spacer

Detailed Description

All cases will be treated by the induced membrane technique in two stages. In the first stage, thorough debridement of the infected bone and soft tissues and copious lavage will be done.

After radical debridement, primary fixation will be done by either external fixation or antibiotic cement coated internally fixed implants.If there is a bone defect, it will be measured and filled with an antibiotic-impregnated (PMMA) cement spacer. The second stage procedure will be performed 4 to 8 weeks after the first one if soft tissue permits and only if there is no clinical or biochemical evidence of ongoing infection as indicated by normal white blood cell count, C-reactive protein, and erythrocyte sedimentation rate. It includes the exchange of the antibiotic cement spacer by a cancellous bone graft.

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Results of the Staged Surgical Approach for Management of Infected Un-united Femoral Shaft Fractures in Adults
Anticipated Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Change in the patient-reported clinical outcome as assessed using the WOMAC Osteoarthritis Index from enrollment to 1-year follow-up after the definitive stage. [from enrollment to one year follow up after the definitive stage.]

    WOMAC is composed of 24 items over 3 subscales (5 for pain, 2 for stiffness, and 17 for physical function). Participants can rate their difficulty for each item.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age between 18 and 65 years old.

  2. Type 32 according to Arbeitsgemeinschaft für Osteosynthesefragen classification in adults.

Exclusion Criteria:
  1. Patients with deficient soft tissue coverage with exposed bone.

  2. Patients with reflex sympathetic dystrophy.

  3. Spinal injuries associated with neurological complications affecting the lower limbs.

  4. Associated head injury affecting the conscious level or the motor power of the injured limb.

  5. Associated mutilating limb injury or peripheral amputation.

  6. Bone defect more than 6 cm in length.

  7. Chronic peripheral ischemia of the limb.

  8. Past history of pathological fractures.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Principal Investigator: Michael G. Waheeb, Msc ortho, Assiut University , 71515 Assiut, Arab Republic of Egypt.
  • Study Chair: Osama Farouk, MD ortho, Assiut University , 71515 Assiut, Arab Republic of Egypt.
  • Study Director: Hossam MA Abubeih, MD ortho, Assiut University , 71515 Assiut, Arab Republic of Egypt.
  • Study Director: Mahmoud Badran, MD ortho, Assiut University , 71515 Assiut, Arab Republic of Egypt.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Michael Girgis Waheeb Tawfeek, Orthopaedic Surgeon, Assiut University
ClinicalTrials.gov Identifier:
NCT04681846
Other Study ID Numbers:
  • Fracture-related infection
First Posted:
Dec 23, 2020
Last Update Posted:
Dec 23, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Michael Girgis Waheeb Tawfeek, Orthopaedic Surgeon, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2020